Kalee E. Rumfelt

Kalee E. Rumfelt

Auto-generated profile, based on publicly available information

Kalee E. Rumfelt

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
AVAndrew L. Valesano
Andrew L. Valesano
KRKalee E. Rumfelt
Kalee E. Rumfelt
DDDerek E. Dimcheff
Derek E. Dimcheff
CBChristopher N. Blair
Christopher N. Blair
WFWilliam J. Fitzsimmons
William J. Fitzsimmons
ALAdam Lauring
Adam Lauring
Analysis of SARS-CoV-2 genetic diversity within infected hosts can provide insight into the generation and spread of new viral variants and may enable high resolution inference of transmission chains. However, little is known about temporal aspects of SARS-CoV-2 intrahost diversity and the extent to which shared diversity reflects convergent evolution as opposed to transmission linkage. Here we use high depth of coverage sequencing to identify within-host genetic variants in 325 specimens from hospitalized COVID-19 patients and infected employees at a single medical center. We validated our variant calling by sequencing defined RNA mixtures and identified viral load as a critical factor in variant identification. By leveraging clinical metadata, we found that intrahost diversity is low and does not vary by time from symptom onset. This suggests that variants will only rarely rise to appreciable frequency prior to transmission. Although there was generally little shared variation across the sequenced cohort, we identified intrahost variants shared across individuals who were unlikely to be related by transmission. These variants did not precede a rise in frequency in global consensus genomes, suggesting that intrahost variants may have limited utility for predicting future lineages. These results provide important context for sequence-based inference in SARS-CoV-2 evolution and epidemiology.

1 August 2020 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
JSJennifer Smith
Jennifer Smith
WZWei Zhao
Wei Zhao
MYMiao Yu
Miao Yu
KRKalee E. Rumfelt
Kalee E. Rumfelt
PMPriya Moorjani
Priya Moorjani
SKSharon L.R. Kardia
Sharon L.R. Kardia

23 December 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
KRKalee E Rumfelt
Kalee E Rumfelt
MPMindy Pike
Mindy Pike
JSJennifer E Stolarczuk
Jennifer E Stolarczuk
ALAva Lekander
Ava Lekander
ALAdam Lauring
Adam Lauring
AKAlisa B Kachikis
Alisa B Kachikis
Background: Immunization against influenza and respiratory syncytial virus (RSV) protects pregnant individuals and their infants against infection via transplacental transport of immunoglobulin G (IgG). We sought to evaluate the quantity and efficiency of maternal influenza- and RSV-specific IgG transfer in pregnancies with preterm and full-term deliveries. Methods: Delivery samples from 115 maternal-infant pairs (2018-2021) were analyzed for RSV prefusion F and IAV-H3 and IAV-H1 antibodies using electrochemiluminescence assays. We used Wilcoxon rank sum tests, t tests, Pearson correlation coefficients (PCCs), and linear regression to evaluate distributions of IgG results by maternal influenza vaccination status and preterm birth (<37 weeks). Results: Approximately 70% of pregnant persons received influenza vaccine. Maternal and cord antibody concentrations were highest in the influenza-vaccinated group for IAV-H3 and IAV-H1 regardless of preterm birth status (maternal H3, P = .004; cord H3, P = .03; maternal H1, P = .0001; cord H1, P = .0002). Preterm infants had significantly lower cord to maternal IgG transfer ratios for IAV-H3 and RSV when compared with full-term infants (P ≤ .05). Correlations between maternal and cord IgG concentrations were significant (P ≤ .001) for all 3 viruses, with the strongest correlation for H3 (PCC: IAV-H3, 0.77; IAV-H1, 0.68; RSV, 0.62). Associations between maternal IgG transfer and preterm birth were significant for IAV-H3 and RSV (IAV-H3, β = −0.42; RSV, β = −0.63; P ≤ .05). Conclusions: Maternal antibody following vaccination or infection is readily transferred across the placenta. Preterm infants have higher influenza IgG following maternal influenza vaccination and are at highest risk of lower IgG transfer ratios without vaccination.

28 June 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
AKAlisa B Kachikis
Alisa B Kachikis
KRKalee Rumfelt
Kalee Rumfelt
MPMindy Pike
Mindy Pike
MSMonica Sosa
Monica Sosa
JSJennifer E Stolarczuk
Jennifer E Stolarczuk
JEJanet A Englund
Janet A Englund
Respiratory syncytial virus (RSV)–associated lower respiratory tract infection contributes significantly to morbidity/mortality worldwide in low birthweight (LBW) infants (<2500 g). Studies have demonstrated decreased maternal immunoglobulin G (IgG) transfer of various antibodies to LBW infants. We aimed to evaluate naturally acquired RSV anti–prefusion F protein (anti-preF) antibody transfer in pregnancies with LBW versus normal birthweight (NBW) infants. In this cohort study conducted among pregnant individuals and their infants, we tested paired maternal and singleton infant cord samples for RSV anti-preF IgG via an electrochemiluminescence immunoassay, using linear regression to evaluate associations between LBW and anti-preF IgG. Covariates included seasonality, insurance, small-for-gestational-age birthweight, and gestational age at delivery. We tested maternal/cord RSV anti-preF IgG from 54 and 110 pregnancies with LBW and NBW infants, respectively. Of LBW infants, 22 (40.7%) were born both preterm and with small-for-gestational-age birthweight. The median (interquartile range) gestational age at delivery and birthweight were 34.0 (31.7–37.1) weeks and 1902 (1393–2276) g for LBW infants versus 39.1 (38.3–39.9) weeks and 3323 (3109–3565) g for NBW infants (both P < .001). In unadjusted comparisons, preterm infants had significantly lower cord anti-preF IgG levels and cord-maternal IgG ratios compared with full-term infants, while LBW infants had significantly lower cord-maternal IgG ratios than NBW infants (all P < .01). After adjustment for covariates, there was no difference in cord-maternal IgG ratios (β =−0.29 [95% confidence interval, −.63 to .05]) between LBW and NBW infants. We documented robust transfer of maternal RSV anti-preF IgG in pregnancies with both LBW and NBW infants. Further studies are needed to assess immune protection in at-risk infants.

1 March 2021 in medRxiv
Verified
Preprint
Open access
PDF file
DDDerek E. Dimcheff
Derek E. Dimcheff
AVAndrew L. Valesano
Andrew L. Valesano
KRKalee E. Rumfelt
Kalee E. Rumfelt
WFWilliam J. Fitzsimmons
William J. Fitzsimmons
CBChristopher Blair
Christopher Blair
ALAdam Lauring
Adam Lauring
Understanding viral load in patients infected with SARS-CoV-2 is critical to epidemiology and infection control. Previous studies have demonstrated that SARS-CoV-2 RNA can be detected for many weeks after symptom onset. The clinical significance of this finding is unclear and, in most patients, likely does not represent active infection. There are, however, patients who shed infectious virus for weeks. Detection of subgenomic RNA transcripts expressed by SARS-CoV-2 has been proposed to represent productive infection and may be a tractable marker for monitoring infectivity. Here, we use RT-PCR to quantify total and subgenomic nucleocapsid (N) and envelope (E) transcripts in 190 SARS-CoV-2 positive samples collected on hospital admission. We relate these findings to duration of symptoms. We find that all transcripts decline at the same rate; however, subgenomic E becomes undetectable before other transcripts. In Kaplan-Meier analysis the median duration of symptoms to a negative test is 14 days for sgE and 25 days for sgN. There is a linear decline in subgenomic RNA compared to total RNA suggesting subgenomic transcript copy number is highly dependent on copy number of total transcripts. The mean difference between total N and subgenomic N is 16-fold (4.0 cycles) and the mean difference between total E and sub-genomic E is 137-fold (7.1 cycles). This relationship is constant over duration of symptoms allowing prediction of subgenomic copy number from total copy number. Although Subgenomic E is undetectable at a time that may more closely reflect the duration of infectivity, its utility in determining active infection may be no more useful than a copy number threshold determined for total transcripts.

3 April 2025 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
KRKalee E Rumfelt
Kalee E Rumfelt
CJCasey Juntila
Casey Juntila
MSMatthew Smith
Matthew Smith
ACAmy Callear
Amy Callear
YYYangyupei Yang
Yangyupei Yang
EMEmily T Martin
Emily T Martin
Background: Little is known about the strength and durability of protection provided by prefusion F (pre-F) immunoglobulin G (IgG) after respiratory syncytial virus (RSV) infection/exposure. Methods: We analyzed 1019 sera from 422 individuals in 173 households, collected 365 days before and after RSV infection or exposure (2014–2022), from a longitudinal cohort with active respiratory infection surveillance. IgG against RSV pre-F was measured by electrochemiluminescence assay. We used a Cox model, adjusted for age, to assess the association between log4 preinfection/exposure IgG and risk of infection. We compared pre- and postinfection/exposure IgG geometric mean concentration increases among cases and household contacts to identify asymptomatic infections. Generalized additive mixed models predicted IgG concentrations over time. Results: We identified 113 confirmed RSV cases and 377 exposed household contacts. Cases had significantly lower pre-F IgG before infection (P < .05) and significantly higher levels after infection (P < .05). A 1-unit increase in log4 preinfection IgG decreased the risk of infection by 25% (P < .05). Among 58 cases with pre- to post-RSV geometric mean concentration increases, the mean fold increase was 1.12. Eight individuals without confirmed infections had ≥1.12-fold increases and were classified as probable asymptomatic infections. Cases had the highest IgG concentrations after infection, peaking at 1 month (P < .001). Conclusions: Pre-F IgG is a reliable correlate of protection for RSV infection risk. We found that RSV pre-F IgG–mediated protection starts to wane 6 months after infection. Therefore, scheduling of RSV vaccination should be evaluated so that individuals with the highest risk of severe disease are protected throughout the RSV season.